Limit search to available items
Book Cover
E-book
Author Petersen, Mitchell A., author

Title Vioxx : too risky for Merck? / Mitchell A. Petersen, Rashmi Singhal
Published London : Kellogg School of Management, 2007
Online access available from:
Sage Business Cases    View Resource Record  

Copies

Description 1 online resource : illustrations
Series SAGE Knowledge. Cases
SAGE Knowledge. Cases
Summary The case outlines the poor decision making by executives of the pharmaceutical company Merck that resulted in its launching of the drug Vioxx and then stalling the withdrawal of the product. The student is invited to consider what caused executives and managers to make bad decisions and how these can be avoided in the future
Notes Originally published in Peterson, M. A., & Singhal, R. (2007). Vioxx: Too risky for Merck?. 5-207-253. Evanston, IL: Kellogg School of Management at Northwestern University
Description based on XML content
Subject Merck-Medco (Firm)
Rofecoxib.
Drugs -- Safety measures.
Form Electronic book
Author Singhal, Rashmi, author
ISBN 9781526449597 (ebook)